The recent advance and prospect of natural source compounds for the treatment of heart failure

Xing-Juan Chen1, Si-Yuan Liu2, Si-Ming Li1

  • 1China Academy of Chinese Medical Sciences Guang'anmen Hospital, Beijing, 100053, China.

Heliyon
|March 6, 2024
PubMed

Insights

Natural products offer a promising avenue for heart failure treatment due to their mild efficacy and low toxicity. This review explores their mechanisms and active ingredients, inspiring new drug development for cardiac insufficiency.

Area of Science:

  • Cardiology
  • Pharmacology
  • Natural Products Research

Background:

  • Heart failure is a progressive syndrome of cardiac insufficiency, a major global health concern and leading cause of death in cardiovascular disease patients.
  • Complex pathophysiological mechanisms, including hemodynamic abnormalities and myocardial remodeling, underlie heart failure symptoms like dyspnea and fatigue.
  • Current treatments involve cardiac glycosides, diuretics, ACE inhibitors, vasodilators, and beta-blockers, but natural products present unique advantages.

Purpose of the Study:

  • To review recent advancements in the mechanisms and active ingredients of natural products for treating heart failure.
  • To highlight the therapeutic potential of natural products in managing cardiac insufficiency.
  • To inspire the development of novel, potent clinical drugs for heart failure based on natural sources.

Main Methods:

  • Literature review focusing on natural products and their active compounds relevant to heart failure.
  • Analysis of mechanisms of action for identified natural products.
  • Synthesis of recent research findings on efficacy and safety profiles.

Main Results:

  • Natural products exhibit mild efficacy, low toxicity, and multi-target comprehensive effects beneficial for heart failure.
  • Active ingredients from natural sources show potential in restoring cardiac function and improving quality of life.
  • Natural products can help reduce energy disorders associated with heart failure.

Conclusions:

  • Natural products represent a valuable resource for developing new heart failure therapies.
  • Further research into natural product mechanisms and active ingredients can lead to improved treatments for cardiac insufficiency.
  • The unique advantages of natural products offer a promising direction for future drug discovery in cardiology.

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
429
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
586
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
375
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
338
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Antianginal Drugs: Nitrates and β-Blockers01:16

Antianginal Drugs: Nitrates and β-Blockers

In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates,  such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
586